Navigation Links
NuVasive Announces Webcast and Conference Call of Fourth Quarter and Full Year 2007 Results
Date:1/25/2008

software-driven nerve avoidance system; MaXcess(R) a unique split-blade design retraction system; and specialized implants, like SpheRx(R) and CoRoent(R), that collectively minimize soft tissue disruption during spine surgery while allowing maximum visualization and surgical reproducibility. NuVasive's product offering is also focused on cervical internal fixation products and its R&D pipeline emphasizes both MAS and motion preservation.

NuVasive cautions you that statements included in this press release that are not a description of historical facts are forward-looking statements that involve risks, uncertainties, assumptions and other factors which, if they do not materialize or prove correct, could cause NuVasive's results to differ materially from historical results or those expressed or implied by such forward-looking statements. The potential risks and uncertainties that could cause actual growth and results to differ materially include, but are not limited to: the uncertain process of seeking regulatory approval or clearance for NuVasive's products or devices, including risks that such process could be significantly delayed; the possibility that the FDA may require significant changes to NuVasive's products or clinical studies; the risk that products may not perform as intended and may therefore not achieve commercial success; the risk that competitors may develop superior products or may have a greater market position enabling more successful commercialization; the risk that additional clinical data may call into question the benefits of NuVasive's products to patients, hospitals and surgeons; and other risks and uncertainties more fully described in NuVasive's press releases and periodic filings with the Securities and Exchange Commission. NuVasive's public filings with the Securities and Exchange Commission are available at http://www.sec.gov. NuVasive assumes no obligation to update any forward-lookin
'/>"/>

SOURCE NuVasive, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. NuVasive to Host Investor Reception on September 11, 2007
2. NuVasive to Present at Thomas Weisel Partners Healthcare Conference
3. US Oncology Announces Realignment of Executive Team
4. Arena Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Second Generation Niacin Receptor Agonist Under Its Collaboration With Merck & Co., Inc.
5. Exelixis Announces January 31 Webcast of Presentation at the 2008 Wachovia Healthcare Conference
6. Cardica Announces Fiscal 2008 Second Quarter Financial Results and Business Progress
7. Neurocrine Biosciences Announces Conference Call and Webcast to Present Fourth Quarter and Year End 2007 Financial Results
8. Gerson Lehrman Group Announces Partnership With BIO to Provide Scientific Expertise for the BIO CEO & Investor Conference
9. Accuray Announces New Treatment Planning Service Offering
10. QED International Associates Announces Changes to the HealthShares(TM) Composite, HealthShares(TM) Cancer and HealthShares(TM) Neuroscience Indexes
11. Sharps Compliance Corp. Announces Purchase of Medical Waste Disposal Facility and Addition of Autoclave Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... (PRWEB) July 28, 2014 Appistry, ... services that bring the power of genomics to next-generation ... Appistry Pipeline Challenge . , Two Appistry ... of the National Center for Genome Resources, and Mr. ... and Clinics of Kansas City. Rounding out the panel ...
(Date:7/28/2014)... 28, 2014 Research and Markets has ... Market 2014-2018" report to their offering. ... is a technique used to determine the size of a ... is crucial to analyze the size of particles as it ... analysis is performed to determine the behavior and nature of ...
(Date:7/25/2014)... -- Trillions of bacteria live in each person,s digestive ... digest food and stave off harmful infections, but their ... To help shed light on the role of these ... professor Eric Alm recently tracked fluctuations in the bacterial ... The findings, described in the July 25 issue of ...
(Date:7/25/2014)... The Conferee Networking committee is pleased ... Networking. These two-hour sessions provide a unique networking opportunity ... problems, discuss new techniques, or brainstorm new ideas in ... topic for consideration is August 31, 2014, and instructions ... Networking committee will review the topics, and status notifications ...
Breaking Biology Technology:Appistry Names Industry Experts from the National Center for Genome Resources and Mercy Children's, Kansas City, to Judge Pipeline Challenge Competition 2Global Particle Size Analysis Market 2014-2018 2Monitoring the rise and fall of the microbiome 2Monitoring the rise and fall of the microbiome 3Pittcon 2015 Announces Call for Topics for Conferee Networking Sessions 2
... DxTech Enters Into Long-Term Strategic Alliance With Nicholas Piramal ... Point-of-Care Diagnostic ... DxTech LLC,("DxTech"), an innovation company focused on putting high-quality,diagnostic ... has entered,into a long-term strategic alliance with Nicholas Piramal ...
... of Sepracor Inc. (Nasdaq: SEPR ), ... Limited (ASX: HTW) today announced that,veteran healthcare executive ... as a non- executive director, effective immediately., ... chief executive,officer and chairman of Marlborough, MA-based Sepracor ...
... PARIS, April 30 ExonHit Therapeutics S.A.,(Alternext: ALEHT), ... its Supervisory Board., Following the annual shareholders, ... 25th, 2008, Mr. Edmund Olivier de Vezin,s appointment ... of the Board, expired,as he has reached the ...
Cached Biology Technology:DxTech and Nicholas Piramal in POC Diagnostics Alliance 2DxTech and Nicholas Piramal in POC Diagnostics Alliance 3DxTech and Nicholas Piramal in POC Diagnostics Alliance 4DxTech and Nicholas Piramal in POC Diagnostics Alliance 5HeartWare Appoints Timothy J. Barberich to Board of Directors 2Frederic Desdouits Appointed Member of the Supervisory Board of ExonHit Therapeutics 2Frederic Desdouits Appointed Member of the Supervisory Board of ExonHit Therapeutics 3
(Date:7/28/2014)... that the effects of a commonly used anesthetic drug ... The study, published in this week,s issue of the ... at the University of California, San Diego and Weill ... concerns, arising from multiple studies on humans over the ... increase their susceptibility to long-term cognitive and behavioral deficits, ...
(Date:7/28/2014)... Ore. The findings of a new study suggest two ... may not work as well in obese women, compared to ... pills are a one-size-fits-all method, researchers say, but as the ... well the pill works for obese women. Studies have consistently ... in the body, which may in turn affect how well ...
(Date:7/28/2014)... 28, 2014) Rice University researchers are using magnetic ... flexibility that can be used as microscale models for ... "bead-spring" polymers, introduced as theory in the 1950s, can ... and should be of interest to materials scientists who ... led by Rice chemical and biomolecular engineer Sibani Lisa ...
Breaking Biology News(10 mins):Study suggests disruptive effects of anesthesia on brain cell connections are temporary 2Study suggests disruptive effects of anesthesia on brain cell connections are temporary 3Strategies identified to improve oral contraceptive success with obese women 2Seeing is bead-lieving 2
... 2013  The following is being released by Wake Forest ... What:  A briefing for ... developments at Wake Forest Baptist Medical Center. Speakers are ... John D. McConnell , ...
... newly described species Alburnoides manyasensis , belongs the large ... as he carps, the minnows, and their relatives. This is ... of vertebrate animals, with the remarkable numbers of over 2,400 ... the largest part of biomass in most water types except ...
... to Research Careers) Program has announced the travel award ... 2013 meeting in Woods Hole, MA from March 9-14, ... of underrepresented minority students, postdoctorates and scientists into the ... the participation of young scientists at The Histochemical Society ...
Cached Biology News:Wake Forest Innovations Announces New Commercialization Developments 2